Dosidal · South Korea
헤몰빈큐플러스캡슐
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | South Korea |
|---|---|
| Record | kr:presentation:kd:8806998009801 (version 1) |
| Level | presentation |
| Pack code | gtin: 08806998009801 |
| Identifiers | gtin: 08806998009801 kr-standard-code: 8806998009801 kr-mfds-item: 200809301 |
| Source authority | HIRA / MFDS |
| Read date | 2026-11-15T05:00:21Z |
| authorisation status | lifecycle: current note: HIRA standard-code mapping status; MFDS authorisation status not read state: current · read 2026-11-15T05:00:21Z · source: 건강보험심사평가원 (HIRA) - 의약품표준코드, via data.go.kr page |
| controlled status | category: 해당사항없음 controlled: False state: current · read 2026-11-15T05:00:21Z · source: 건강보험심사평가원 (HIRA) - 의약품표준코드, via data.go.kr page |
| identity | atc: B03AE01 company: 제이에스제약(주) item_approval_date: 2008-09-05 marking: 바코드 mfds_item_code: 200809301 product_name: 헤몰빈큐플러스캡슐 serial_number_omitted: Y serial_omission_reason: 일반의약품 spec: 326.1밀리그램 standard_code: 8806998009801 total_quantity: 0 transfer_applied: 2014-10-21 transfer_ended: 2020-06-22 state: current · read 2026-11-15T05:00:21Z · source: 건강보험심사평가원 (HIRA) - 의약품표준코드, via data.go.kr page |
| pack product code | check_digit_ok: True gtin: 08806998009801 published_by: HIRA representative_code: 8806998009801 standard_code: 8806998009801 state: current · read 2026-11-15T05:00:21Z · source: 건강보험심사평가원 (HIRA) - 의약품표준코드, via data.go.kr page |
| prescription class | as_published: 일반의약품 class: non_prescription state: current · read 2026-11-15T05:00:21Z · source: 건강보험심사평가원 (HIRA) - 의약품표준코드, via data.go.kr page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53yv9-3A77p_2iJx-bQMd1oetY46qFZXdCSQUUpKysTnpw-hPmtPuBnMfHpaCpIAk91sGMUCx2fQ2FrgVH008tRgVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |
JSON: https://dosidal-api.ai/v1/records/kr:presentation:kd:8806998009801 · Same medicine in other markets · Dosidal